IRIS
GARGIULO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.919
EU - Europa 3.252
NA - Nord America 2.909
SA - Sud America 804
AF - Africa 107
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.779
SG - Singapore 2.684
RU - Federazione Russa 1.783
CN - Cina 1.048
BR - Brasile 667
IT - Italia 553
HK - Hong Kong 551
VN - Vietnam 318
DE - Germania 188
NL - Olanda 163
FI - Finlandia 112
GB - Regno Unito 84
IN - India 75
IE - Irlanda 74
CA - Canada 70
UA - Ucraina 70
FR - Francia 64
KR - Corea 63
AR - Argentina 57
SE - Svezia 44
MX - Messico 37
CI - Costa d'Avorio 30
AT - Austria 27
BD - Bangladesh 27
EC - Ecuador 27
ID - Indonesia 23
ZA - Sudafrica 23
TR - Turchia 21
IQ - Iraq 18
PL - Polonia 17
JP - Giappone 14
PY - Paraguay 13
ES - Italia 12
CO - Colombia 11
KE - Kenya 11
CH - Svizzera 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
CZ - Repubblica Ceca 9
LT - Lituania 8
MA - Marocco 8
DO - Repubblica Dominicana 6
JO - Giordania 6
PE - Perù 6
PK - Pakistan 6
SA - Arabia Saudita 6
BO - Bolivia 5
DZ - Algeria 5
EG - Egitto 5
IR - Iran 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AU - Australia 4
AZ - Azerbaigian 4
BE - Belgio 4
UY - Uruguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
AO - Angola 3
BB - Barbados 3
GT - Guatemala 3
IL - Israele 3
IS - Islanda 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
AL - Albania 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
KH - Cambogia 2
ME - Montenegro 2
MG - Madagascar 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
PG - Papua Nuova Guinea 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EU - Europa 1
Totale 11.978
Salva come PNG Salva come JPEG
Città #
Singapore 1.258
Hong Kong 551
Moscow 425
Hefei 322
Ashburn 296
Chandler 284
Beijing 270
Millbury 169
Amsterdam 137
Santa Clara 120
Ho Chi Minh City 116
Los Angeles 104
Naples 103
Princeton 75
Des Moines 73
Buffalo 70
Nanjing 66
Lawrence 62
São Paulo 62
Napoli 61
Seoul 60
Hanoi 59
Redondo Beach 59
Munich 57
Boston 56
New York 55
Dallas 33
Wilmington 33
Ottawa 29
Frankfurt am Main 28
Dong Ket 25
The Dalles 23
Nanchang 21
Rio de Janeiro 21
Helsinki 20
Jacksonville 20
Atlanta 19
Boardman 19
Orem 19
Tianjin 19
Chennai 18
Montreal 18
Nuremberg 18
Rome 18
Chicago 17
Haiphong 17
Mexico City 17
Turku 17
Washington 17
Belo Horizonte 16
Milan 16
Brooklyn 15
Stockholm 15
Denver 14
San Francisco 14
Brasília 13
Seattle 13
Tokyo 13
Warsaw 13
Augusta 12
Johannesburg 12
Norwalk 12
West Jordan 12
Ankara 11
Hebei 11
London 11
Quito 11
Afragola 10
Lappeenranta 10
Nairobi 10
New Delhi 10
Vienna 10
Biên Hòa 9
Curitiba 9
Houston 9
Phoenix 9
Poplar 9
San Mateo 9
Shenyang 9
Toronto 9
Da Nang 8
Guarulhos 8
Jakarta 8
Kronberg 8
Kunming 8
Manchester 8
Praia Grande 8
Buenos Aires 7
Changsha 7
Guayaquil 7
Jiaxing 7
Mumbai 7
Nova Iguaçu 7
Redwood City 7
Ribeirão Preto 7
Santiago 7
Shanghai 7
São Bernardo do Campo 7
Torre del Greco 7
Woodbridge 7
Totale 5.959
Salva come PNG Salva come JPEG
Nome #
Aspirin Monotherapy After BioFreedom Stent and 1-Month DAPT 184
Akap1 Regulates Vascular Function and Endothelial Cells Behavior 151
LA TRANSATTIVAZIONE Gβγ-DIPENDENTE DEL RECETTORE DELL’EGF E’ MEDIATA DAL RECETTORE DELL’UROTENSINA II 143
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry 139
Correction: Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 139
Moderate to severe mitral regurgitation in patients undergoing trancatheter aortic valve replacement: a meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,933 patients 133
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 130
IDENTIFICAZIONE PROTEOMICA DI UN NUOVO FATTORE COINVOLTO NELLA MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 124
PKA Phosphorylation regulates frataxin mitochondrial targeting in pressure overload-induced cardiac hypertrophy 120
A kinase anchor protein 121 regulates mitochondrial function and survival in cardiac and smooth muscle cells 116
Effects of Successful Percutaneous Lower Extremity Revascularization on Cardiovascular Outcome in Patients with Peripheral Arterial Disease 115
RUOLO DELL’UNCOUPLING PROTEIN 3 IN CONDIZIONI IPOSSICO-ISCHEMICHE 113
Protective Role of Uncoupling Protein 3 Under Hypoxic Conditions in vitro and in the Pathogenesis of Post-ischemic Cardiac Remodelling in vivo. 113
Adverse Post-Ischemic Cardiac Remodeling in Chronic Hindlimb Ischemia: Proteomic Identification of a Novel Molecular Mechanism 113
Contemporary Evidence and Practice on Right Heart Catheterization in Patients with Acute or Chronic Heart Failure 111
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 111
Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome 109
Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. 109
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 107
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 106
Cardioprotective role of Urotensin (UT II)- mediated transactivation of the EGFR. 106
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 106
Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. 106
Contemporary use and results of intra-aortic balloon pump counterpulsation. 103
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 102
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 101
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes 101
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal 100
Il secondo messaggero cAMP e la regolazione della funzione cardiaca: ruolo dell'adenilato ciclasi. 100
Quinacrine as a Novel Anti-Restenotic and Anti-Thrombotic Drug for Coronary Artery Interventions. 100
Increased mortality after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and low ejection fraction: A meta-analysis of 6898 patients 100
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes 99
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 99
Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report . 98
Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management. 98
Molecular modulation of post-ischemic cardiac remodeling by hindlimb ischemia 98
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 97
AngioJet rheolytic thrombectomy for acute superficial femoral artery stent or femoropopliteal by-pass thrombosis 95
Complete Revascularization in Acute and Chronic Coronary Syndrome 95
Lung Ultrasound in Coronary Care Unit, an Important Diagnostic Tool for Concomitant Pneumonia 94
Title: Competitive displacement of a kinase anchor protein 121 from mitochondria triggers DNA damage and lowers tolerance to oxidative stress in muscle cells 94
Prevenzione della restenosi e della trombosi intrastent: ruolo del derivato acridinico quinacrina 94
A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation 94
AKAP121 controls mitochondrial function and survival of cardiomyocytes. 93
Rotational atherectomy for the treatment of isolated femoral artery traumatic lesion: A case report 93
Ruolo del derivato acridinico Quinacrina nella prevenzione della restenosi e della trombosi intrastent. 92
RUOLO PROTETTIVO DELL’UNCOUPLING PROTEIN 3 IN UN MODELLO MURINO DI INFARTO MIOCARDICO ACUTO 92
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation 92
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 91
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis 91
AKAP121 mithocondrial delocalization increases oxidative stress and promotes cell death in the mouse heart. 90
Use of statins in lower extremity artery disease: a review 90
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 90
Crosslink between atrial fibrillation and cancer: a therapeutic conundrum 89
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 89
Quinacrine as a novel drug in the prevention of in-stent restenosis and thrombosis. 88
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 88
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 87
Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review 87
Role of Phosphoinositide 3-kinases and Angiogenesis in Cardiovascular Diseases. 86
ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial 85
Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study 83
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 82
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches 82
A Kinase Anchor Protein 121 regulates mitochondrial function and survival in cardiac and muscle cells. 80
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure 80
New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association? 80
EGFR Trans-activation by Urotensin II Receptor is Mediated by Beta-arrestin Recruitment and Confers Cardioprotection in Pressure Overload-induced Cardiac Hypertrophy. 80
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 79
L’assenza dell’Uncoupling Protein 3 (UCP3) determina l’aumento della mortalità in un modello murino di infarto miocardico. 73
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-analysis 68
Bivalirudin Versus Unfractionated Heparin for Acute Coronary Syndromes: Do We Have a Winner? 67
Activated Clotting Time During Unfractionated Heparin-Supported Coronary Intervention: Is Access Site the New Piece of the Puzzle? ∗ 67
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry 67
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial 66
Bivalirudin in Current Practice: Melius Abundare Quam Deficere?∗ 66
The multiplication of loaves and fishes approach: a critic todoubleanti-thrombotics or todoublenumber of ischaemic events? 64
Antithrombotic therapy in TAVI patients: Changing concepts 64
New cerebral lesions at magnetic resonance imaging after carotid artery stenting versus endarterectomy: an updated meta-analysis 63
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 63
Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supra-aortic trunks : case report - online article 62
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention 62
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 61
STOPDAPT-3 subanalysis on prasugrel monotherapy after elective or emergent coronary intervention in patients with or without diabetes: are we ready for this? 60
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions 60
Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication 60
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 60
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 59
Sex‐Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria 57
Response by Gargiulo et al to Letter Regarding Article, “Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial” 56
The Effects of Cangrelor on Platelet Aggregation in STEMI Patients 56
RUOLO PROTETTIVO DELL'UNCOUPLING PROTEIN 3 (UCP3) NELLA MALATTIA ISCHEMICA. 56
Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation 56
Assessing vascular complexity of PAOD patients by deep learning-based segmentation and fractal dimension 55
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis 55
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 55
Nuovi concetti nella segnalazione beta-adrenergica: prospettive terapeutiche per lo scompenso cardiaco.. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. 55
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 55
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. 54
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 54
Totale 8.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021181 0 0 0 0 0 28 18 11 44 4 49 27
2021/2022649 20 1 10 3 15 12 6 28 89 32 106 327
2022/2023759 140 64 8 47 84 80 10 46 96 137 31 16
2023/2024722 21 97 82 52 29 84 12 48 56 34 132 75
2024/20254.221 237 339 18 49 62 117 459 237 366 409 1.457 471
2025/20264.905 903 944 892 779 1.200 187 0 0 0 0 0 0
Totale 12.307